Clinical Trials Browser

Uveal Melanoma × Nivolumab × CNS × Clear all

NCT05341349 2025-07-30

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Phase 1 Active not recruiting

CNSDermatologic

Uveal Melanoma, Brain Neoplasms, Melanoma